Bethanechol for urinary retention: exclude obstruction, watch cholinergic effects

How bethanechol works and who it is for

Bethanechol mimics acetylcholine at parasympathetic receptors. It increases tone in the detrusor muscle, often enough to start urination and empty the bladder, and it also stimulates stomach and bowel motility. Unlike acetylcholine it resists rapid breakdown by cholinesterase, and it does not cross the blood-brain barrier, so its effects are mainly peripheral.

It is indicated for acute postoperative and postpartum non-obstructive retention and for neurogenic atony of the bladder. Its role is modest: the MSD Manual notes that acute retention is relieved by catheterisation, and that bethanechol is usually ineffective for an underactive detrusor. Exam questions therefore focus on safe use rather than on how well it works. Expect a care plan that also addresses the cause, such as reviewing anticholinergic drugs, treating constipation and encouraging early mobility.

Exclude obstruction before the first dose

Bethanechol is contraindicated with mechanical obstruction, bladder neck obstruction, recent bladder surgery, recent bowel anastomosis, possible bowel obstruction and peritonitis. Forcing the bladder to contract against a blocked outlet is the problem: if the sphincter fails to relax, urine may be pushed up the ureter toward the kidney, and with bacteriuria this can cause reflux infection.

Before giving it, assess for distension above the pubic bone, measure post-void residual with a bladder scan as ordered, and ask about stream, straining and prostate history. Review constipation and anticholinergic drugs, which commonly cause retention. If findings suggest obstruction, or the bladder is painfully full, hold the dose and contact the prescriber about catheterisation.

Cholinergic effects and contraindications to check

Adverse effects follow from widespread muscarinic stimulation: abdominal cramps, nausea, belching, diarrhoea, salivation, urinary urgency, headache, flushing, sweating, tearing, small pupils, a fall in blood pressure with reflex tachycardia, and bronchial constriction with asthma attacks. They are more frequent after subcutaneous injection and at higher doses. Dizziness on standing is possible, so teach slow position changes.

Check the history before the first dose. Contraindications include asthma, marked bradycardia or hypotension, coronary artery disease, hyperthyroidism, peptic ulcer, epilepsy and parkinsonism. Record baseline heart rate, blood pressure and breath sounds. Patients receiving ganglion-blocking drugs can have a critical fall in blood pressure.

Giving it safely and knowing the antidote

Give oral bethanechol on an empty stomach, one hour before or two hours after meals, because taking it soon after food can cause nausea and vomiting. Effects may start within 30 minutes and peak at 60 to 90 minutes, so make sure the call bell, toilet or commode are within reach and record the volume voided.

Early signs of excess are abdominal discomfort, salivation, flushing, sweating, nausea and vomiting. Atropine is the specific antidote and can abolish bethanechol's effects promptly, so know where it is kept, particularly when the drug is injected. Report wheeze, bradycardia or fainting at once, and recheck post-void residual as ordered to judge whether the drug is helping. Document the time of each dose alongside voiding times and volumes so the team can see whether it is working.

Apply it to a scenario

Consider a hypothetical 72-year-old man who has not voided for eight hours after hernia repair. He has a history of benign prostatic hyperplasia with a weak stream, and oral bethanechol has been ordered. Options include giving it now with lunch, giving it and rechecking in an hour, or holding it, scanning the bladder and reporting the prostate history.

Holding the dose and reporting is the strongest answer, because prostatic enlargement raises the possibility of outlet obstruction, which is a contraindication. Giving it with lunch adds the error of dosing with food. In practice the prescriber may order catheterisation and review the cause before any drug is used.

Sources and further reading

DailyMed: Bethanechol chloride tablets prescribing information. Mechanism, indications, contraindications including obstruction and asthma, reflux risk, adverse effects, empty-stomach dosing, onset and atropine as antidote.

MedlinePlus: Bethanechol. Patient teaching on empty-stomach dosing and conditions to report before use.

MSD Manual Professional: Urinary retention. Causes including obstruction and anticholinergic drugs, post-void residual assessment and catheterisation for acute retention.

MSD Manual Professional: Urinary incontinence in adults. Bethanechol is usually ineffective for detrusor underactivity, with cholinergic adverse effects.